These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4200481)

  • 41. [Susceptibility of Pseudomonas aeruginosa recently isolated from clinical specimens to various antimicrobial agents and changes of susceptibility to carbenicillin, gentamicin and amikacin (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1980 Jun; 33(6):668-74. PubMed ID: 6779031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [In vitro effects of the combination of carbenicillin with gentamicin or tobramycin with respect to Pseudomonas aeruginosa].
    Turgeon PL; Croteau L
    Union Med Can; 1977 May; 106(5):682-5. PubMed ID: 405784
    [No Abstract]   [Full Text] [Related]  

  • 43. [Carbenicillin and gentamycin. In vitro investigations of 2 broad-spectrum antibiotics active against Pseudomonas aeruginosa].
    Rosdahl N; Thomsen VF
    Ugeskr Laeger; 1971 Sep; 133(37):1817-22. PubMed ID: 5001170
    [No Abstract]   [Full Text] [Related]  

  • 44. Hospital isolates of Serratia marcescens transferring ampicillin, carbenicillin, and gentamicin resistance to other gram-negative bacteria including Pseudomonas aeruginosa.
    Olexy VM; Bird TJ; Grieble HG; Farrand SK
    Antimicrob Agents Chemother; 1979 Jan; 15(1):93-100. PubMed ID: 106772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Laboratory studies on antibiotic chemotherapy of Pseudomonas aeruginosa infections (author's transl)].
    Kobayashi Y; Tomioka S; Hasegawa M
    Jpn J Antibiot; 1977 Mar; 30(3):209-14. PubMed ID: 404446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Various methods to assay carbenicillin activity against Pseudomonas aeruginosa].
    Litovchenko PP; Dekhtiar NV; Keĭsevich LV; Lukach IG
    Antibiot Khimioter; 1991 Nov; 36(11):17-21. PubMed ID: 1793288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship of resistance phenotype to the R-pyocin susceptibility pattern in clinical isolates of Pseudomonas aeruginosa.
    Petrocheilou-Malliara K; Koukoubanis N; Legakis N
    Chemioterapia; 1987 Jun; 6(2 Suppl):199. PubMed ID: 3151341
    [No Abstract]   [Full Text] [Related]  

  • 48. [Sensitivity of Pseudomonas aeruginosa to gentamicin and carbenicillin].
    Spieckermann C
    Med Welt; 1969 Sep; 36():1973-6. PubMed ID: 4980293
    [No Abstract]   [Full Text] [Related]  

  • 49. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.
    Klastersky J; Nyamubeya B; Vandenborre L
    J Med Microbiol; 1974 Nov; 7(4):465-72. PubMed ID: 4217836
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antibiotic associations on acting Pseudomonas aeruginosa].
    Duval J; Mathieu-Saint-Laurent P; Soussy CL
    Pathol Biol (Paris); 1971; 19(11):637-48. PubMed ID: 4997792
    [No Abstract]   [Full Text] [Related]  

  • 51. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F; Akhtar N; Hameed A
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin.
    Phair JP; Watanakunakorn C; Bannister T
    Appl Microbiol; 1969 Sep; 18(3):303-6. PubMed ID: 4984762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Letter: Resistant pseudomonads in a neurosurgical unit.
    Seal DV; Strangeways JE
    Lancet; 1975 Jan; 1(7897):48-9. PubMed ID: 46376
    [No Abstract]   [Full Text] [Related]  

  • 54. [The effect of gentamicin and other antibiotics on the pathogenic germs in urinary tract infections (author's transl)].
    Schmid W
    Med Klin; 1973 Dec; 68(50):1652-6. PubMed ID: 4205807
    [No Abstract]   [Full Text] [Related]  

  • 55. Pseudomonas aeruginosa virulence factors: modifications by sub-inhibitory concentrations of carbenicillin or gentamicin.
    Ogaard AR; Bjøro K; Bukholm G; Berdal BP
    Acta Pathol Microbiol Immunol Scand B; 1986 Apr; 94(2):63-8. PubMed ID: 3088910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Level of resistance of clinical isolates of Pseudomonas aeruginosa as related to their susceptibility to phages and R-pyocins.
    Legakis N; Koukoubanis N; Malliara K; Tumah H
    Chemioterapia; 1987 Jun; 6(2 Suppl):200-1. PubMed ID: 3151342
    [No Abstract]   [Full Text] [Related]  

  • 57. Biological aspects of the interaction between gentamicin and carbenicillin.
    Waitz JA; Drube CG; Moss EL; Oden EM; Bailey JV
    J Antibiot (Tokyo); 1972 Apr; 25(4):219-25. PubMed ID: 4626239
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies on the combined action of antibiotics on Pseudomonas aeruginosa strains.
    Muszyński Z; Kedzia W
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):743-51. PubMed ID: 4358926
    [No Abstract]   [Full Text] [Related]  

  • 59. Gentamicin resistance in Pseudomonas aeruginosa: R-factor-mediated resistance.
    Bryan LE; Shahrabadi MS; van den Elzen HM
    Antimicrob Agents Chemother; 1974 Aug; 6(2):191-9. PubMed ID: 15828191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Study on the sensibility "in vitro" to antibiotics of 77 strains of "Pseudomonas aeruginosa" (author's transl)].
    Padovani F; Pilotti C
    Ann Sclavo; 1976; 18(5):749-54. PubMed ID: 829305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.